FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

23 letters match. Newest first.

  1. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  2. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  3. The Platinum Healthcare LLC

    The Platinum Healthcare LLC sells unapproved new drugs 'Sycosis' and 'Syphillinum' online for STIs, FDA warns.

    High risk
  4. DesBio/Deseret Biologicals, Inc.

    FDA says DesBio’s CHLA:10M, sold online for Chlamydia symptoms, is an unapproved new drug.

    High risk
  5. RoyceDerm LLC

    FDA says RoyceDerm LLC marketed Herpes Relief Cream, an unapproved new drug, for herpes symptoms on its website.

    High risk
  6. Good Stuff Cacao

    FDA warns Good Stuff Cacao that disease claims make its cacao, tea, honey, goji unapproved new drugs.

    Low
  7. PReye, LLC

    FDA warned PReye, LLC that its unapproved eye drop PReye Vitamin SEE was made without sterile controls in an unclassified office.

    High risk
  8. Herbal Dermals LLC FZ dba Gotucream

    FDA warned Herbal Dermals LLC FZ dba Gotucream that its Gotucream balanitis cream is an unapproved new drug.

    Low
  9. MantroForce

    MantroForce marketed five sexual-health and prostate products as unapproved new drugs, FDA says.

    High risk
  10. Wholesale Peptide

    FDA warns Wholesale Peptide that its website sells Prostamax and Gonadorelin as unapproved new drugs.

    High risk
  11. Texinkart Inc.

    Texinkart Inc. sold four Ayurvedic products online without FDA drug approval, FDA says.

    High risk
  12. Eden Health International Inc. dba Eden

    FDA warned Eden Health International that its telehealth website misbrands compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  13. GSC Products, LLC

    FDA told GSC Products its Sinus Plumber headache nasal spray is an unapproved new drug sold online without FDA approval.

    High risk
  14. Supersmart USA, LLC

    FDA says Supersmart USA sold dietary supplements with disease-treatment claims, making them unapproved and misbranded drugs.

    Low
  15. Lovega LLC dba Pink Pony Peptides

    FDA warned Pink Pony Peptides that its GLP-2 TZ, GLP-3 RT and Bacteriostatic Water are unapproved new drugs sold online.

    High risk
  16. Gram Peptides

    Gram Peptides sold unapproved injectable peptide drugs and bacteriostatic water online as new drugs, FDA says.

    High risk
  17. Prime Sciences

    Prime Sciences sells injectable peptide drugs and BAC water online without FDA approval, FDA says.

    High risk
  18. PekCura Labs

    FDA warned PekCura Labs that its GLP-1-S, GLP-2-T, GLP-3-R, and bacteriostatic water products are unapproved new drugs sold online.

    High risk
  19. Weightless Medical LLC dba WeightCare

    FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.

    Low
  20. Alan Health Technologies Inc. dba Alan

    FDA warns Alan Health Technologies over website falsely labeling compounded semaglutide and tirzepatide as Alan-made.

    Low
  21. BluefitMD

    FDA warned BluefitMD that its website falsely labels compounded semaglutide and tirzepatide as its own and as FDA-approved.

    Low
  22. Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics

    FDA warned Deluxe IV and Aesthetics over misleading website claims for compounded semaglutide and tirzepatide, including implying FDA approval.

    Low
  23. Beach Weekend Management LLC dba Nic and Jet Fuel

    FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.

    Medium